[Tumor inhibiting and immunoloregulation effects of Mylabris Mixture on H22 cancer-bearing mice].
Zhong Xi Yi Jie He Xue Bao
; 4(5): 504-8, 2006 Sep.
Article
en Zh
| MEDLINE
| ID: mdl-16965746
OBJECTIVE: To investigate the mechanisms of tumor inhibiting and immunoloregulation of Mylabris Mixture on H22 cancer-bearing mice. METHODS: H22 cancer-bearing mice were chosen to observe the effects of tumor inhibiting and detect the proliferation function of T lymphocytes, the toxicity function of NK cells, the changes of T lymphocytes and the contents of interferon-gamma and interleukin-4. RESULTS: Mylabris Mixture could obviously inhibit the growth of H22 cancer in mice, and the tumor inhibition rat was 65.76%. The stimulation index of T lymphocyte transformation and percentage of NK cells in Mylabris Mixture-treated group were obviously higher than those in the normal control group. The subpopulation proportion of T lymphocytes in Mylabris Mixture-treated group was changed more than the normal control group. The production of interferon-gamma and interleukin-4 by T lymphocytes obviously increased in Mylabris Mixture-treated group (P<0.05, P<0.001). CONCLUSION: Mylabris Mixture has the effect of inhibiting the growth of tumor constitution, and regulating immunological function on mice with tumor. Its mechanisms include the reinforcement of T lymphocyte immune function, NK cell killing function and humoral immune function.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Escarabajos
/
Protocolos de Quimioterapia Combinada Antineoplásica
/
Neoplasias Hepáticas Experimentales
Tipo de estudio:
Clinical_trials
Límite:
Animals
/
Humans
/
Male
Idioma:
Zh
Revista:
Zhong Xi Yi Jie He Xue Bao
Asunto de la revista:
MEDICINA
/
TERAPIAS COMPLEMENTARES
Año:
2006
Tipo del documento:
Article
País de afiliación:
China
Pais de publicación:
China